Bevacizumab Versus Triamcinolone Acetonide for the Treatment of Keloids.
Clinical trial NCT07014280 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07014280
- Sponsor
- Kasr El Aini Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2024-09-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.